Related Experiment Video
Updated: Jun 17, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Heart disease in thalassemia intermedia
A Aessopos1, M Tsironi, A Andreopoulos
1First Department of Internal Medicine, University of Athens Medical School, Laiko General Hospital, Athens, Greece. aaisopos@cc.uoa.gr
Hemoglobin
|December 17, 2009
Summary
Thalassemia intermedia (TI) involves a spectrum of conditions, with cardiovascular issues being a major cause of death. Understanding these complications is key to managing TI patients and preventing heart failure.
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Thalassemia intermedia (TI) exhibits a wide clinical range, from severe transfusion-dependent thalassemia major (TM) to asymptomatic carriers.
- Cardiovascular complications are the leading cause of mortality in both TM and TI.
- Multiple factors contribute to cardiovascular abnormalities in TI, impacting patient outcomes.
Purpose of the Study:
- To elucidate the complex pathophysiology of cardiovascular complications in Thalassemia Intermedia.
- To identify key factors contributing to cardiac dysfunction and heart failure in TI patients.
Main Methods:
- Review of existing literature on cardiovascular complications in Thalassemia Intermedia.
- Analysis of reported pathophysiological mechanisms, including vascular, endothelial, and cardiac factors.
- Synthesis of information on the impact of these factors on cardiac remodeling and heart failure.
Main Results:
- Cardiovascular complications are the primary cause of mortality in Thalassemia Intermedia.
- Contributing factors include high output state, vascular abnormalities, endothelial dysfunction, elastic tissue disorders, hypercoagulability, and iron overload.
- These mechanisms lead to biventricular remodeling and ultimately heart failure.
Conclusions:
- Cardiovascular complications are a critical determinant of morbidity and mortality in Thalassemia Intermedia.
- A multifactorial etiology underlies cardiac dysfunction in TI, necessitating comprehensive management strategies.
- Further research into these mechanisms can guide therapeutic interventions to improve long-term outcomes for TI patients.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...